Sign in
ERYP Stock Price, Chart, Stats & News
ERYTECH Pharma S.A.
Save
47.38M
Market cap
–
Current P/E
–
Forward P/E
ERYP chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | 177.82% |
ROA | -0.50% |
ROE | -0.98% |
D/E | 0.58x |
Interest coverage ratio | -2.05x |
ERYP valuation
P/E | – |
P/S | – |
P/B | 0.89x |
P/CF | -0.66x |
P/FCF | -1.29x |
P/OCF | -0.66x |
PEG | -1.06x |
EV multiple | -2.92x |
About
ERYTECH Pharma S. A. is a biopharmaceutical company specializing in the clinical development of red blood cell-based treatments for various cancers and orphan diseases. Its operations are based in France and the United States.
Similar securities
Based on sector and market capitalization
Report issue